View Post

Where Cancer-killing T-cells Come From

In In The News by Barbara Jacoby

By: Shirley Dang From: parkerici.org New research published today in Nature Medicine by scientists from the Stanford University School of Medicine and the Parker Institute for Cancer Immunotherapy sheds new light on the origins of tumor-fighting immune cells following immunotherapy treatment with anti-PD-1 checkpoint inhibitors. Using single-cell RNA sequencing technology, the group discovered that T-cells homing in on cancer did …

View Post

I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

In Clinical Trials by Barbara Jacoby

Source: I-MAB Pharma From: prnewswire.com I-Mab Biopharma (“I-Mab”), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products Administration (NMPA) has approved its investigational new drug (IND) application for TJC4, a differentiated fully human CD47 monoclonal antibody internally developed for the treatment of advanced malignant …

View Post

Study Confirms Disparities in Triple-Negative Breast Cancer Diagnoses

In In The News by Barbara Jacoby

Source: Wiley Research News From: prnewswire.com A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, shows that women of color and young women may face elevated risks of developing triple-negative breast cancers, which are often aggressive and do not respond to hormone therapy or targeted therapy. Previous U.S. studies have found racial disparities in triple-negative …

View Post

Untire, The First App for Cancer-Related Fatigue Now Available for Free

In In The News by Barbara Jacoby

Millions of people around the world suffer from cancer-related fatigue Untire, the first mobile app to address Cancer-Related Fatigue (CRF), is now available for free. Fatigue is the most common side effect of cancer and its treatment. Almost 40% of all cancer patients and survivors suffer from severe and prolonged fatigue. Untire’s easy-to-use self-management program provides support to the millions …

View Post

Liquid Biopsy Assay From MSKCC Approved by New York State

In In The News by Barbara Jacoby

By: Staff Reporter From: genomeweb.com Memorial Sloan Kettering Cancer Center said today that New York state has approved the center’s liquid biopsy test for noninvasive cancer genomic profiling and disease monitoring. The test, called Analysis of Circulating cfDNA to Evaluate Somatic Access (MSK-ACCESS), has been clinically validated and implemented by MSK’s molecular diagnostics service. It sequences 129 cancer-associated genes selected …

View Post

Underenrollment in clinical trials: Patients not the problem

In Clinical Trials by Barbara Jacoby

By: UT Southwestern Medical Center From: medicalxpress.com The increasing sophistication of cancer treatments threatens to outpace the ability of health care providers to enroll patients in clinical trials to test those therapies. That’s a key finding by researchers in UT Southwestern’s new Department of Population and Data Sciences. The authors of the study published this month in the Journal of …

View Post

Sorry Princess Leia, but a Clinical Trial is My Only Hope

In Clinical Trials by Barbara Jacoby

By: Sarah DeBord From: curetoday.com I have two perspectives as I look at clinical trials: as the patient needing one and as an advocate encouraging patients to enroll in them. But how can I encourage someone to do something that I personally find so frustrating? Sarah DeBord was diagnosed with metastatic colon cancer at age 34. In the years since, …

View Post

As Cancer Survivors Increase, Hardships Remain

In In The News by Barbara Jacoby

By: Gaby Galvin From: usnews.com A growing and aging population will lead to more people who have battled the disease, highlighting a need for stronger support for survivors. The number of cancer survivors in the U.S. is set to rise by more than 5 million by 2030, according to a new analysis from the American Cancer Society. Researchers estimate more …